Biotest Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Jorg Schuttrumpf
Chief executive officer
€395.0k
Total compensation
| CEO salary percentage | 49.62% |
| CEO tenure | 4.2yrs |
| CEO ownership | n/a |
| Management average tenure | 4.2yrs |
| Board average tenure | 3.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2025 | n/a | n/a | -€24m |
| Dec 31 2024 | €395k | €196k | €26m |
| Sep 30 2024 | n/a | n/a | €69m |
| Jun 30 2024 | n/a | n/a | €164m |
| Mar 31 2024 | n/a | n/a | €177m |
| Dec 31 2023 | €707k | €294k | €127m |
| Sep 30 2023 | n/a | n/a | €91m |
| Jun 30 2023 | n/a | n/a | -€10m |
| Mar 31 2023 | n/a | n/a | -€47m |
| Dec 31 2022 | €737k | €294k | -€32m |
Compensation vs Market: Jorg's total compensation ($USD458.77K) is below average for companies of similar size in the German market ($USD1.96M).
Compensation vs Earnings: Jorg's compensation has been consistent with company performance over the past year.
CEO
Jorg Schuttrumpf (51 yo)
Dr. Jorg Schuttrumpf is CEO & Chairman of Management Board of Biotest Aktiengesellschaft from May 28, 2025 and serves as its Member of Management Board since 2022. Dr. Schuttrumpf serves as Chief Scientifi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman of Management Board | 4.2yrs | €395.00k | no data | |
| Employee Representative Member of Supervisory Board | 4.2yrs | €44.00k | no data | |
| Head of Investor Relations | no data | no data | no data | |
| Head of Corporate HR | 10.6yrs | no data | no data |
Experienced Management: BIO's management team is considered experienced (4.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Employee Representative Member of Supervisory Board | 3.8yrs | €44.00k | no data | |
| Member of Supervisory Board | 2.8yrs | €44.00k | no data | |
| Chairman of the Supervisory Board | 3.8yrs | €132.00k | no data | |
| Shareholder Representative Member of Supervisory Board | 1.3yrs | €5.00k | no data | |
| Shareholder Representative Member of Supervisory Board | 3.8yrs | €44.00k | no data |
Experienced Board: BIO's board of directors are considered experienced (3.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/23 19:19 |
| End of Day Share Price | 2026/03/20 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Biotest Aktiengesellschaft is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Torben Teichler | Hauck Aufhäuser Investment Banking |
| Jan Keppeler | HSBC |
| Klaus Schlote | Solventis Wertpapierhandelsbank GmbH |